Matrix metalloproteinases in destructive pulmonary pathology.
about
Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 declineEarly elevation of serum MMP-3 and MMP-12 predicts protection from World Trade Center-lung injury in New York City firefighters: a nested case-control studyNovel adjunctive therapies for the treatment of tuberculosisAnti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIVMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisEpithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposureTuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary diseaseMatrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyPhosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologyEffect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosisMMP-2 and TIMP-1 predict healing of WTC-lung injury in New York City firefightersEffect of inhaled tiotropium on spirometric parameters in patients with tuberculous destroyed lungChanges in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detectionAcute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in ratsPersistence of oxidant and protease burden in the airways after smoking cessation.Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study.Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.Arhgef1 regulates alpha5beta1 integrin-mediated matrix metalloproteinase expression and is required for homeostatic lung immunityFibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patientsPulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema.Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke.MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitroThe risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis.Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice.Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severityIdentification of neutrophil activation markers as novel surrogate markers of CF lung disease.The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosisPredominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.Deficiency of matrix metalloproteinase-13 increases inflammation after acute lung injuryBronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report.Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung DiseaseRespiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidantsMolecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice.
P2860
Q23918414-D8623281-BD3D-402E-B680-AAE6708CB755Q23921517-304B7417-10EB-4F22-B68F-7D4E5C3D06F1Q26829957-92898602-7BFA-4F06-AD2E-39E9501D822BQ27011921-C153BBBD-2E35-41F1-91DF-299C7415A75EQ28256930-82E6F319-9284-4481-BB50-3AC6B7A1BAC3Q28385959-4648F5D9-3010-4AA0-ACC1-2458ED1A2CACQ28389187-E0251157-A6EB-4EB0-A169-0A1BA54DD003Q28389802-53978E96-80FC-4F51-9CF7-C2B755D89435Q28389823-B11264C1-F448-43F8-81A9-3485884FD95DQ28394883-F5F0C1A0-9E6F-4C13-9098-A86ED4EDD16BQ28395449-A3ABEDB2-2E8D-474E-B8B2-A0480DFAEA59Q28397030-D70368A2-8337-4EA7-B3D5-D0CE6D1FDBCCQ28397325-9D13B1EC-B4E5-4760-8CF5-8124F6882CFEQ28568515-A9855A29-763C-4AF5-8018-DD7B18CF9529Q33453893-9552762C-F806-41ED-ADD0-1F61A10BDDC4Q33540363-71448578-19D7-4A9D-85B0-4A03BF304DFEQ33623697-CFA37152-2030-4E54-8B2A-59F8B5DCAF22Q33703665-8E804FB4-5D4F-4F76-9DF3-382248D235A5Q33727178-3D2444AC-71B7-4D93-B56D-013B47BD86D3Q33732176-F5D5C6D3-43B8-4B7B-866C-5B74B519F959Q33762362-C8CC2F42-93DA-42AF-B1A0-101A581E194CQ33923363-BB1D3FC3-209B-424A-BD63-4C4F03EC571EQ33983140-79B022BA-9BD0-48BF-9489-63BD8D4CB484Q34033301-014B629F-547C-4690-8BA2-19EAB7E96D7FQ34058316-4995F28B-1BB1-407B-9583-E2713DE60EF7Q34062984-3C69E235-AFDE-4977-8E0E-35E31C725F12Q34066783-CB86F85C-B2F2-4A25-8BDB-94028B1AC9E5Q34128938-65BBF8C0-F051-434E-8F8F-69C9C7F7C1AAQ34539996-C0A333B6-E87C-49AF-9C02-95823FB87023Q34598673-327312B3-869C-48AC-B628-BEBFEEE9A407Q34611437-83AB9324-8579-4B7B-9F1D-752A94F4B16BQ34784319-4A598287-4753-40F7-B084-973D13B55094Q35542502-EE731A24-AB13-4E78-AAA4-A09928109010Q35563366-C4FCAB7B-B6C0-406A-863F-2495C8FA3780Q35776317-B9DABA6B-6D73-4D03-A667-D16E59B95850Q35914790-4CB1FA99-7499-48EF-8665-978E1CDE1CB4Q36036223-5888B82E-2440-4C96-B505-1F443F679986Q36102809-73D8AA59-6219-4C8F-9738-CF5B5E2870A6Q36104532-E9E68607-8824-4702-824D-4A9FFBECB061Q36115224-C4E1CDE0-5A71-4A8F-A417-01F24A1BA77F
P2860
Matrix metalloproteinases in destructive pulmonary pathology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Matrix metalloproteinases in destructive pulmonary pathology.
@ast
Matrix metalloproteinases in destructive pulmonary pathology.
@en
type
label
Matrix metalloproteinases in destructive pulmonary pathology.
@ast
Matrix metalloproteinases in destructive pulmonary pathology.
@en
prefLabel
Matrix metalloproteinases in destructive pulmonary pathology.
@ast
Matrix metalloproteinases in destructive pulmonary pathology.
@en
P2860
P356
P1433
P1476
Matrix metalloproteinases in destructive pulmonary pathology.
@en
P2093
J S Friedland
P T G Elkington
P2860
P304
P356
10.1136/THX.2005.051979
P407
P577
2005-10-14T00:00:00Z